Publicaciones en las que colabora con Estefanía Toledo Atucha (2)

2021

  1. Final results regarding the addition of dendritic cell vaccines to neoadjuvant chemotherapy in early HER2-negative breast cancer patients: clinical and translational analysis

    Therapeutic Advances in Medical Oncology, Vol. 13

2007

  1. BY55/CD160 cannot be considered a cytotoxic marker in cytomegalovirus- specific human CD8+ T cells

    Clinical and Experimental Immunology, Vol. 149, Núm. 1, pp. 87-96